Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition
Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs
Combination of Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population
Comparison of two mechanical disaggregation methods of fresh lung tissues for extraction of high-quality RNA
Correction to: Prevalence and type of MMR expression heterogeneity in colorectal adenocarcinoma: therapeutic implications and reporting
Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres
Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives
BRAFV600E immunohistochemistry can reliably substitute BRAF molecular testing in the Lynch syndrome screening algorithm in colorectal cancer
U?estalost idh1/2 mutacija u bolesnika s dijagnozom akutne mijeloi?ne leukemije – pilot studija kbc zagreb
